Catalyst Wire Dossier Catalyst Wire Dossier

Levact

liposomal daunorubicin
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Levact, covering 2023-01-04 to 2023-01-04. Get the full timeline:

Most recent: Clinical Trial Update: Hodgkin Lymphoma Treatment With Adcetris and Levact in the Old Patient [Phase 1, Phase 2]

See pricing